Immune cell clues could lead to better allergy eye treatments
NCT ID NCT07171307
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 22 times
Summary
This study will compare immune cells in the blood and tears of 60 people with allergic conjunctivitis—some who have received allergy shots and some who have not—along with healthy volunteers. Researchers want to understand how certain immune cells (Tregs and Th2 cells) work and how they relate to disease severity and treatment response. The goal is to find markers that could guide future therapies, but this study does not test any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONJUNCTIVITIS, ALLERGIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto de Oftalmología FAP Conde de Valenciana, IAP Sede Centro
Mexico City, Mexico City, 06800, Mexico
Conditions
Explore the condition pages connected to this study.